Please select the option that best describes you:
Would you consider stopping nivo/ipi combination after a CR in a patient with metastatic melanoma?
Answer from: Medical Oncologist at Community Practice
Indirect data indeed suggest we can extrapolate the data on durable complete response after discontinuation of pemrolizumab. Indeed, most patients in complete response who stopped ipi/nivo combination for toxicity or any other reason in Checkmate 067 and 069 had durable ongoing complete response. Af...
Sign in or Register to read more